Elizabeth Merikle
Overview
Explore the profile of Elizabeth Merikle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
452
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brown V, Merikle E, Johnston K, Gooch K, Audhya I, Lowes L
J Patient Rep Outcomes
. 2023 Dec;
7(1):129.
PMID: 38085412
Background: Duchenne muscular dystrophy (DMD) is a rare, severe, fatal neuromuscular disease characterized by progressive atrophy and muscle weakness, resulting in loss of ambulation, decreased upper body function, and impaired...
2.
Johnston K, Casstevens C, Patel V, Merikle E, Presnall C, Audhya I
Adv Ther
. 2023 Mar;
40(5):2296-2310.
PMID: 36917428
Introduction: Limb girdle muscular dystrophies (LGMDs) are a group of rare and heterogeneous disorders involving progressive wasting of shoulder and pelvic girdle musculature. This study aimed to generate qualitative evidence...
3.
Berry-Kravis E, Hagerman R, Budimirovic D, Erickson C, Heussler H, Tartaglia N, et al.
J Neurodev Disord
. 2022 Nov;
14(1):56.
PMID: 36434514
Background: Fragile X syndrome (FXS) is associated with dysregulated endocannabinoid signaling and may therefore respond to cannabidiol therapy. Design: CONNECT-FX was a double-blind, randomized phase 3 trial assessing efficacy and...
4.
Patel V, Patroneva A, Glaze D, Davis Ms K, Merikle E, Revana A
J Clin Sleep Med
. 2021 Aug;
18(2):485-496.
PMID: 34437052
Study Objectives: Excessive daytime sleepiness is common in Prader-Willi syndrome (PWS), with prevalence ranging from 52% to 100%. The goal of this study was to establish the content validity (ie,...
5.
Gibson A, Smiell J, Yu T, Boing E, McClure E, Merikle E, et al.
Burns
. 2021 Mar;
47(4):978.
PMID: 33685811
No abstract available.
6.
Gibson A, Smiell J, Yu T, Boing E, McClure E, Merikle E, et al.
Burns
. 2020 Dec;
47(5):1066-1073.
PMID: 33303264
Reducing the amount of donor skin needed for definitive wound closure can improve outcomes in patients with severe burns. This Delphi Consensus Panel (DCP) aimed to achieve expert consensus on...
7.
Szabo S, Merikle E, Lozano-Ortega G, Powell L, Macek T, Cline S
Schizophr Res Treatment
. 2019 Jan;
2018:9075174.
PMID: 30687553
Objective: To perform a systematic review of the published literature to evaluate how functional capacity, as measured by the University of California at San Diego (UCSD) Performance-based Skills Assessment (UPSA),...
8.
Davis M, O Connell T, Johnson S, Cline S, Merikle E, Martenyi F, et al.
Curr Alzheimer Res
. 2018 Jan;
15(8):777-788.
PMID: 29357799
Background: Alzheimer's Disease (AD) can be conceptualized as a continuum: patients progress from normal cognition to mild cognitive impairment (MCI) due to AD, followed by increasing severity of AD dementia....
9.
Gauthier G, Guerin A, Zhdanava M, Jacobson W, Nomikos G, Merikle E, et al.
BMC Psychiatry
. 2017 Jun;
17(1):222.
PMID: 28629442
Background: Although the symptoms of major depressive disorder (MDD) are often manageable with pharmacotherapy, response to first-line antidepressant treatment is often less than optimal. This study describes long-term treatment patterns...
10.
The effect of vortioxetine on overall patient functioning in patients with major depressive disorder
Florea I, Loft H, Danchenko N, Rive B, Brignone M, Merikle E, et al.
Brain Behav
. 2017 Mar;
7(3):e00622.
PMID: 28293465
Background: The objectives of this meta-analysis of data from randomized, placebo-controlled studies were to assess the effect of vortioxetine on overall functioning (primary) and functional remission (secondary) using the Sheehan...